Invasive aspergillosis complicating pandemic influenza A (H1N1) infection in severely immunocompromised patients

Clinical Infectious Diseases

Volumn 53, Issue 6, 2011, Pages

  Garcia Vidal, Carolina ^a,b   Barba, Pere ^c   Arnan, Montse ^d   Moreno, Asunción ^e   Ruiz Camps, Isabel ^b,c   Gudiol, Carlota ^a,b   Ayats, Josefina ^a,f   Ortí, Guillermo ^d   Carratal, Jordi ^a,b  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^d HOSPITAL DURAN I REYNALS   (Spain)

^e HOSPITAL CLÍNIC   (Spain)

^f INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; ANIDULAFUNGIN; CYTARABINE; ETOPOSIDE; IDARUBICIN; OSELTAMIVIR; POSACONAZOLE; VORICONAZOLE;

ADULT; AGED; ARTICLE; BRONCHOSCOPY; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOCOMPROMISED PATIENT; INFLUENZA A (H1N1); INVASIVE ASPERGILLOSIS; LABORATORY TEST; MALE; NEUTROPENIA; NOSE SMEAR; PANDEMIC INFLUENZA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; THORAX RADIOGRAPHY;

AGED; ASPERGILLOSIS; DISEASE OUTBREAKS; FATAL OUTCOME; FEMALE; HUMANS; IMMUNOCOMPROMISED HOST; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; LEUKEMIA, MYELOID, ACUTE; LIVER TRANSPLANTATION; MALE; MIDDLE AGED;

EID: 80052196060     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cir485     Document Type: Article

References (12)

1. Marr KA, Carter RA, Boeckh M, et al. Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors. Blood 2002; 100:4358-66. (Pubitemid 35429674)
2. Gavalda J, Len O, San Juan R, et al. Risk factors for invasive aspergillosis in solid-organ transplant recipients: a case-control study. Clin Infect Dis 2005; 41:52-9. (Pubitemid 40863744)
3. Choi SM, Boudreault AA, Xie H, et al. Differences in clinical outcomes following 2009 influenza A/H1N1 and seasonal influenza among hematopoietic cell transplant recipients. Blood 2011; 117:5050-6.
4. Kumar A, Michaels M, Morris M, et al. Outcomes from pandemic influenza A H1N1 infection in recipients of solid-organ transplants: a multicentre cohort study. Lancet Infect Dis 2010; 10:521-6.
5. de Pauw B, Walsh TJ, Donnelly JP, et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycosis Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 2008; 46:1813-21.
6. Martino R, Piñana JL, Parody R, et al. Lower respiratory tract respiratory virus infections increase the risk of invasive aspergillosis after a reduced-intensity allogeneic hematopoietic SCT. Bone Marrow Transplant 2009; 44:749-56.
7. Garcia-Vidal C, Upton A, Kirby KA, et al. Epidemiology of invasive mold infections in allogeneic stem cell transplant recipients: biological risk factors for infection according to time alter transplantation. Clin Infect Dis 2008; 47:1041-50.
8. Lat A, Bhadelia N, Miko B, et al. Invasive aspergillosis after pandemic (H1N1) 2009. Emerg Infect Dis 2010; 16:971-3.
9. Writing Committee of the WHO Consultation on Clinical Aspects of Pandemic (H1N1) 2009 Influenza. Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection. N Engl J Med 2010; 362:1708-19.
10. Bermejo-Martin JF, Martin-Loeches I, Rello J, et al. Host adaptive immunity deficiency in severe pandemic influenza. Crit Care 2010; 14:R167.
11. Rodilies E, Sein T, Roden M, et al. Elevated serum concentrations of interleukin-10 in nonneutropenic patients with invasive aspergillosis. J Infect Dis 2001; 183:518-20. (Pubitemid 32105614)
12. Gueller S, Allwinn R, Mousset S, et al. Enhanced immune response after a second dose of an AS03-adjuvanted H1N1 influenza A vaccine in patients after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2011; DOI: 10.1016/j.bbmt.2011.02.004.